Article
Do we need another heart failure biomarker: focus on soluble suppression of tumorigenicity 2 (sST2)
27 Dec 2016
Abstract excerpt
Managing patients with heart failure is no easy task. For those of us who delve in the daily ‘fray’ of heart failure, there are a number of situations where appropriate use of biomarkers may lead to better treatment: In patients presenting with dyspnoea, how sure are we of the diagnosis of heart failure? What treatments can I safely start in the hospital? How do I know the appropriate time to discharge a patient?...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.